Compare Arm Holdings plc (ARM) vs Novo Nordisk A/S (NVO) Price & Performance

Arm Holdings plcTrade

Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

Arm Holdings plc vs Novo Nordisk A/S — how do they compare? Arm Holdings plc trades at $273.33 (market cap $287.22B), while Novo Nordisk A/S trades at $45.89 (market cap $207.85B). The key difference: Arm Holdings plc is the larger of the two by market cap, and Novo Nordisk A/S pays a 3.81% dividend while Arm Holdings plc pays none. Which is the better fit depends on your goals.

	ARM	NVO
Market Cap	$287.22B	$207.85B
Sector	Technology	Health
52-Week High	$439.46	$63.98
52-Week Low	$104.55	$35.29
Enterprise Value	$283.79B	$222.55B
Dividend Yield	—	3.81%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ARM

Arm Holdings rated Strong Buy with $33-44B revenue potential from AI CPU market surgeSeeking Alpha · 4 days agoBullish Arm Holdings posts 22% revenue growth, driven by AI and data center demand, with strong long-term outlook.Seeking Alpha · 5 days agoBullish View details →

NVO

Novo Nordisk downgraded to Sell on weak growth and operational issues despite strong semaglutide sales.Seeking Alpha · 5 days agoBearish View details →

About Arm Holdings plc

Arm Holdings designs the architecture for high-performance, energy-efficient processors used in nearly all smartphones and millions of other devices. Its intellectual property powers global computing from mobile to AI.

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.